Dimethylformamide

Dimethylformamide

SCHEMBL3284756

CN(C)C=O.CN(C)P(=O)(N(C)C)N(C)C

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.60
USP2 O75604 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylformamide SCHEMBL28183862 0.87 TSHR (0.45) TSHRUSP2ALOX15
Dimethylformamide SCHEMBL28230075 0.84 TSHR (0.43) TSHRUSP2ALOX15
SCHEMBL3277 0.82 MEN1 (0.33) USP2ALOX15
SCHEMBL10797895 0.82 MEN1 (0.33) USP2ALOX15
Formamide SCHEMBL17223645 0.80 USP2 (0.36) TSHRUSP2ALOX15
Fluoride SCHEMBL29264050 0.78 MEN1 (0.32) USP2ALOX15
SCHEMBL16269363 0.78 MEN1 (0.32) USP2ALOX15
Water SCHEMBL28784578 0.78 ACHE (0.32) USP2ALOX15
SCHEMBL16268590 0.78 MEN1 (0.32) USP2ALOX15
SCHEMBL31642708 0.78 MEN1 (0.32) USP2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150315092-A1 INCREASED LONGEVITY OF THE NITROGEN CONTENT OF SOIL THROUGH IMPROVED LIQUID DELIVERY FORMULATIONS OF NITRIFICATION INHIBITORS DESIGNED FOR UREA AND MANURE BASED FERTILIZERS SOILGENIC TECHNOLOGIES, LLC 2015-11-05 US claimed
US-12030826-B2 Efficiency of man-made and/or natural organic based animal manure fertilizers by liberating the bound nutrients (macro and micro) through the use of organic, non-aqueous liquid delivery formulations containing organic poly (organicacids) and/or their salts SOILGENIC TECHNOLOGIES (US) 2024-07-09 US disclosed
US-20240101494-A1 EFFICIENCY OF MAN-MADE AND/OR NATURAL ORGANIC BASED ANIMAL MANURE FERTILIZERS BY LIBERATING THE BOUND NUTRIENTS (MACRO AND MICRO) THROUGH THE USE OF ORGANIC, NON-AQUEOUS LIQUID DELIVERY FORMULATIONS CONTAINING ORGANIC POLY (ORGANICACIDS) AND/OR THEIR SALTS SOILGENIC TECHNOLOGIES, LLC 2024-03-28 US disclosed
US-11866382-B2 Efficiency of man-made and/or natural organic based animal manure fertilizers by liberating the bound nutrients (macro and micro) through the use of organic, non-aqueous liquid delivery formulations containing organic poly (organicacids) and/or their salts SOILGENIC TECHNOLOGIES, LLC (US) 2024-01-09 US disclosed
US-11352303-B2 Compositions and methods for coating of nitrification inhibitors with a solution containing a high concentration of urease inhibitors WORLD SOURCE ENTERPRISES, LLC (KN) 2022-06-07 US disclosed
US-20210347707-A1 EFFICIENCY OF MAN-MADE AND/OR NATURAL ORGANIC BASED ANIMAL MANURE FERTILIZERS BY LIBERATING THE BOUND NUTRIENTS (MACRO AND MICRO) THROUGH THE USE OF ORGANIC, NON-AQUEOUS LIQUID DELIVERY FORMULATIONS CONTAINING ORGANIC POLY (ORGANICACIDS) AND/OR THEIR SALTS SOILGENIC TECHNOLOGIES, LLC 2021-11-11 US disclosed
US-20210198163-A1 INCREASED LONGEVITY OF THE NITROGEN CONTENT OF SOIL THROUGH IMPROVED LIQUID DELIVERY FORMULATIONS OF NITRIFICATION INHIBITORS DESIGNED FOR UREA AND MANURE BASED FERTILIZERS SOILGENIC TECHNOLOGIES, LLC 2021-07-01 US disclosed
US-10974999-B2 Increased longevity of the nitrogen content of soil through improved liquid delivery formulations of nitrification inhibitors designed for urea and manure based fertilizers SOILGENIC TECHNOLOGIES, LLC 2021-04-13 US disclosed
EP-3073829-B1 NITRIFICATION INHIBITORS DESIGNED FOR UREA AND MANURE BASED FERTILIZERS MCKNIGHT GARY DAVID (US) 2020-05-13 EP disclosed
EP-3639667-A1 NITRIFICATION INHIBITORS DESIGNED FOR UREA AND MANURE BASED FERTILISERS Mcknight, Gary, David (US) 2020-04-22 EP disclosed
US-6060207-A LOW IN ABSORPTION OF A LIGHT SOURCE OF SHORT WAVELENGTH AND EXCELLENT IN DRY ETCH RESISTANCE; COMPRISES A COMPOUND HAVING A TERPENOID SKELETON KABUSHIKI KAISHA TOSHIBA (JP) 2000-05-09 US disclosed
US-5932391-A CONTAINING AN ACYCLIC COMPOUND WHICH IS A VINYL POLYMERBEING LIGHT ABSORBENT KABUSHIKI KAISHA TOSHIBA (JP) 1999-08-03 US disclosed
US-5856318-A Nitrogen-containing cyclohetero cyclo-heteroaminoaryl derivatives for CNS disorders THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-01-05 US disclosed
CN-1199387-A Process for preparation of halogenated alkanes ALLIED SIGNAL INC (US) 1998-11-18 CN disclosed
CN-1154112-A Dinucleoside-5 ', 5' -pyrophosphates LEPETIT SPA (IT) 1997-07-09 CN disclosed
US-5541317-A PENICILLIN DERIVATIVES, CYCLIZATION OF ESTERS OR THIOESTERS SANKYO COMPANY, LIMITED (JP) 1996-07-30 US disclosed
EP-0005348-B1 CARBAPENEM DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BEECHAM GROUP PLC (GB) 1982-09-22 EP disclosed
US-4285954-A INSECTICIDES AND MITICIDES ZOECON CORPORATION (US) 1981-08-25 US disclosed
US-4250182-A Pharmaceutical composition containing acridone compounds and method of using same BURROUGHS WELLCOME CO. (US) 1981-02-10 US disclosed
EP-0005348-A1 Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1979-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352303-B2 Compositions and methods for coating of nitrification inhibitors with a solution containing a high concentration of urease inhibitors ENGASE, SLC14A1, NOS2 TSHR 4017/4885USP2 322/4885ALOX15 4105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.